Usana Health Sciences (USNA) Net Income towards Common Stockholders (2016 - 2026)
Usana Health Sciences (USNA) has disclosed Net Income towards Common Stockholders for 17 consecutive years, with -$1.6 million as the latest value for Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 135.57% to -$1.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.5 million through Jan 2026, down 72.71% year-over-year, with the annual reading at $11.5 million for FY2026, 72.71% down from the prior year.
- Net Income towards Common Stockholders for Q1 2026 was -$1.6 million at Usana Health Sciences, up from -$6.7 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $22.8 million in Q4 2022, with the low at -$6.7 million in Q3 2025.
- Average Net Income towards Common Stockholders over 5 years is $12.8 million, with a median of $14.9 million recorded in 2022.
- The sharpest move saw Net Income towards Common Stockholders rose 12.21% in 2022, then tumbled 162.81% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at $22.8 million in 2022, then decreased by 26.47% to $16.8 million in 2023, then tumbled by 73.26% to $4.5 million in 2024, then crashed by 248.57% to -$6.7 million in 2025, then soared by 76.06% to -$1.6 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at -$1.6 million, -$6.7 million, and $10.4 million for Q1 2026, Q3 2025, and Q2 2025 respectively.